109 related articles for article (PubMed ID: 682760)
1. [Hydroxyquinoline victims in Sweden].
Hansson O
Lakartidningen; 1978 Sep; 75(36):3064-7. PubMed ID: 682760
[No Abstract] [Full Text] [Related]
2. Ethnic differences in drugs and xenobiotics. Clioquinol.
Rose FC
Prog Clin Biol Res; 1986; 214():323-30. PubMed ID: 2941765
[No Abstract] [Full Text] [Related]
3. [SMON syndrome. First case after abuse of a methylated hydroxyquinoline derivative].
Saragoussi JJ; Soffer M; Giraud D; Raison J; Basdevant A; Pouliquen Y
Bull Soc Ophtalmol Fr; 1984 Jan; 84(1):25-8. PubMed ID: 6442219
[No Abstract] [Full Text] [Related]
4. [SMON].
Paal G
MMW Munch Med Wochenschr; 1976 Dec; 118(51):suppl [7]-[8]. PubMed ID: 826814
[No Abstract] [Full Text] [Related]
5. Chinese acupuncture treatment for SMON patients.
Katahira K; Kobayshi T; Higashida T; Kamae S; Nakajima Y; Fujimoto S
Chin Med J (Engl); 1986 Nov; 99(11):910-1. PubMed ID: 2953563
[No Abstract] [Full Text] [Related]
6. [SMON outside Japan--a neurologic evaluation].
Silfverskiöld B
Lakartidningen; 1980 May; 77(19):1821-2. PubMed ID: 7392712
[No Abstract] [Full Text] [Related]
7. Oxyquinoline neurotoxicity.
Guy-Grand B; Basdevant A; Soffer M
Lancet; 1983 Apr; 1(8331):933. PubMed ID: 6132266
[No Abstract] [Full Text] [Related]
8. Oxyquinoline toxicity.
Soffer M; Basdevant A; Sarragoussi JJ; Raison J; Guy-Grand B
Lancet; 1983 Mar; 1(8326 Pt 1):709. PubMed ID: 6132067
[No Abstract] [Full Text] [Related]
9. Transient global amnesia due to clioquinol.
Kaeser HE
Acta Neurol Scand Suppl; 1984; 100():175-83. PubMed ID: 6237545
[TBL] [Abstract][Full Text] [Related]
10. Assessment of neurotoxicity of clioquinol (Enterovioform) by visual evoked potentials. A preliminary communication.
Bhasin DK; Raina R; Mehta SK; Arora MM
Indian J Gastroenterol; 1985 Jul; 4(3):165-6. PubMed ID: 3160659
[No Abstract] [Full Text] [Related]
11. Toxic metabolic disorders of myelin --ophthalmological features.
Lessell S
Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():453-68. PubMed ID: 6675829
[No Abstract] [Full Text] [Related]
12. The aetiology of SMON may involve an interaction between clioquinol and environmental metals.
Tjälve H
Med Hypotheses; 1984 Nov; 15(3):293-9. PubMed ID: 6240588
[TBL] [Abstract][Full Text] [Related]
13. [The history of quinolines].
Wolffers I
Ned Tijdschr Geneeskd; 1985 Jun; 129(26):1246-9. PubMed ID: 3160957
[No Abstract] [Full Text] [Related]
14. Is there SMON in India?
Wadia NH
Neurol India; 1973 Sep; 21(3):95-103. PubMed ID: 4274127
[No Abstract] [Full Text] [Related]
15. Clinical features of SMON.
Toyokura Y; Takasu T
Jpn J Med Sci Biol; 1975; 28 Suppl():87-99. PubMed ID: 136544
[No Abstract] [Full Text] [Related]
16. [Subacute myelo-optic neuritis].
Vanĕcek J; Fink Z
Cesk Pediatr; 1979 Nov; 34(11):661-2. PubMed ID: 160840
[No Abstract] [Full Text] [Related]
17. [Neurological complications in the course of treatment of acrodermatitis enteropathica with oxyquinoline derivatives].
Papuziński M; Wilmowska-Pietruszyńska A
Pediatr Pol; 1974 Nov; 49(11):1393-7. PubMed ID: 4278959
[No Abstract] [Full Text] [Related]
18. Clinical chemistry of clioquinol.
Tamura Z
Jpn J Med Sci Biol; 1975; 28 Suppl():69-77. PubMed ID: 136542
[No Abstract] [Full Text] [Related]
19. [SMON and chinoform].
Tamura Z
Tanpakushitsu Kakusan Koso; 1973 Mar; 18(3):210-4. PubMed ID: 4197094
[No Abstract] [Full Text] [Related]
20. [Abdominal symptoms of subacute myelo-optico-neuropathy (SMON)--with special reference to relationship between chinoform and ileus-like symptoms].
Inoue N; Tamura K; Kuroiwa Y; Ysukochi T; Naritomi T
Rinsho Shinkeigaku; 1973 Sep; 13(9):537-42. PubMed ID: 4796521
[No Abstract] [Full Text] [Related]
[Next] [New Search]
